OCON Therapeutics

Spherical Intrauterine Drug Delivery Platform

Health Tech & Life Sciences
Non Active, Apr 2026 ceased to operate
Series A Modi'in-Maccabim-Re'ut, Israel Founded 2011
LinkedIn
Last updated 2026-06-18
Total raised
$24.5M
Last: 2024-06
Stage
Series A
Founded
2011
Headcount
34
HQ
Modi'in-Maccabim-Re'ut, Israel
Sector
Health Tech & Life Sciences

About

OCON Therapeutics innovates, develops, manufactures, and commercializes women's health products based on its proprietary and patented intrauterine ball (IUB) platform. Made from the super-elastic alloy nitinol, the IUB is an ideal carrier of multiple drugs to the uterus for treating a variety of conditions.

In addition to its flagship product, the IUB Ballerine, OCON Therapeutics is developing a pipeline of products utilizing the IUB frame for indications including abnormal uterine bleeding, heavy menstrual bleeding, myomas and fibroids, and infertility.

Funding history · 8 rounds · $24.5M total

2024-06
2020-12
2020-06
2017-10
Undisclosed
Chemo Group
2016-01
2014-01
2013-05
2011-03

Q&A

What is OCON Therapeutics' current operational status?
OCON Therapeutics is currently inactive, having ceased to operate in April 2026.
What is OCON Therapeutics' primary business focus?
OCON Therapeutics focuses on innovating, developing, manufacturing, and commercializing women's health products based on its proprietary intrauterine ball (IUB) platform.
When was OCON Therapeutics founded?
OCON Therapeutics was founded in March 2011.
How many employees does OCON Therapeutics have?
OCON Therapeutics has 11-50 employees.
What is the total amount of funding OCON Therapeutics has raised to date?
OCON Therapeutics has raised a total of $24,499,999 USD.
When was OCON Therapeutics' most recent funding round and how much was raised?
OCON Therapeutics' most recent funding round was in June 2024, raising $10,000,000 USD.
Which investors participated in OCON Therapeutics' June 2024 funding round?
The June 2024 funding round for OCON Therapeutics included.
What is the primary sector for OCON Therapeutics?
OCON Therapeutics' primary sector is Health Tech & Life Sciences.
Where is OCON Therapeutics headquartered?
OCON Therapeutics is headquartered in Modi'in-Maccabim-Re'ut, Israel.

Team · 1

Ilan Baram
Founder · Co-founder (No longer with the company)
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsCommerce & RetailDistribution ChannelsDistributorConsumersDemographics & FamilyWomen
Business model
B2BB2C

Highlights

1 PatentsVerified

Tags

femtechpreventionmedical-productsmedical-devicespregnancygynecologywomen-healthnon-invasivewomenpatientstreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)